OpiAID

Wilmington, United States

OpiAID to develop an advanced wearable device to aid in treatment for opioid abuse by detecting biological indicators of overdose.

$2.8M raised

May 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OpiAID raised?

OpiAID has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in May 2023.

Who are OpiAID's investors?

OpiAID's investors include One North Carolina Small Business Program, National Institute on Drug Abuse (NIDA).

Where is OpiAID headquartered?

OpiAID is headquartered in Wilmington, United States.

What does OpiAID do?

OpiAID to develop an advanced wearable device to aid in treatment for opioid abuse by detecting biological indicators of overdose.

What stage is OpiAID at?

OpiAID is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 2, 2023.

MLA

"OpiAID — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/opiaid. Accessed July 2, 2026.

APA

VCBacked. (2023). OpiAID — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/opiaid

Wikipedia (cite web)

{{cite web |title=OpiAID — Funding & Investors |url=https://www.vcbacked.co/company/opiaid |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 2, 2023.